臨床婦人科産科63巻8号

2009年08月発行

今月の臨床 若年女性の月経異常を診る

【続発無月経2　続発無月経の治療】

1）視床下部・下垂体性無月経

著者： 寺内公一¹ 久保田俊郎¹

所属機関： ¹東京医科歯科大学医学部附属病院周産・女性診療科

ページ範囲：P.1052 - P.1055

文献概要

はじめに

　視床下部性・下垂体性続発無月経の治療は大きく3群に分けて考えることができる．①器質的病因に対する原因療法，②機能的病因に対する原因療法，③器質的・機能的病因に対する対症療法である．

参考文献

1） Abe T, Ludecke DK : Recent results of primary transnasal surgery for infradiaphragmatic craniopharyngioma. Neurosurg Focus 3 : article 4, 1997

2） Dominguez J, Goodman L, Gupta SS, et al : Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 86 : 92─99, 2007

3） Williams NI, Helmreich DL, Parfitt DB, et al : Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 86 : 5184─5193, 2001

4） Ahima RS, Prabakaran D, Mantzoros C, et al : Role of leptin in the neuroendocrine response to fasting. Nature 382 : 250─252, 1996

5） Welt CK, Chan JL, Bullen J, et al : Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351 : 987─997, 2004

6） Nakamura S, Douchi T, Oki T, et al : Relationship between sonographic endometrial thickness and progestin─induced withdrawal bleeding. Obstet Gynecol 87 : 722─725, 1996

7） Brody SA, Turkes A, Goldzieher JW : Pharmacokinetics of three bioequivalent norethindrone／mestranol─50ug and three norethindrone／ethinyl estradiol─35ug OC formulations : are “low─dose” pills really lower? Contraception 40 : 269─284, 1989

8） DeCherney M : Bone─sparing properties of oral contraceptives. Am J Obstet Gynecol 174 : 15─20, 1996

9） Carr BR, Ory H : Estrogen and progestin components of oral contraceptives : relationship to vascular disease. Contraception 55 : 267─272, 1997

10） Mandel FP, Geola FL, Lu JKH, et al : Biologic effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol 59 : 673─679, 1982

11） Hendrix SL, Wassertheil─Smoller S, Johnson KC, et al : Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113 : 2425─2434, 2006

12） Curb JD, Prentice RL, Bray PF, et al : Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 166 : 772─780, 2006

13） Smith NL, Heckbert SR, Lemaitre RN, et al : Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 292 : 1581─1587, 2004

14） IMS : Updated practical recommendations for hormone replacement therapy in the peri─ and postmenopause. Climacteric 11 : 108─123, 2008

15） NAMS : Estrogen and progestogen use in postmenopausal women : July 2008 position statement of The North American Menopause Society. Menopause 15 : 584─602, 2008